Bronchoscopic intratumoural therapies for non-small cell lung cancer

What is it about?

Systemic treatments for non-small cell lung cancer are typically administered intravenously. However, this is not necessarily the most effective route of administration, especially for several new therapies under development, including immunotherapies. In this article, we explore the recent developments in direct intratumoral injection for the treatment of lung cancer, specifically those that may be administered through a bronchoscope.

Featured Image